Pyoderma - 18 Studies Found

Withdrawn : Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)
: Pyoderma
: 2005-09-16
: Drug: sisomicin
Completed : A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2013-10-15
: Biological: Xilonix IV
Terminated : A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2014-12-08
: Drug: gevokizumab
Terminated : An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2014-12-22
:
  • Drug: gevokizumab
  • Drug: Placebo
Completed : Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2013-06-17
: Drug: gevokizumab
Completed : Canakinumab for Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2011-02-17
: Drug: Canakinumab Monoclonal antibody inhibiting interleukin 1 beta
Recruiting : An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2017-04-27
: Biological: Ixekizumab Injection Other Name: Taltz
Withdrawn : Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2008-08-04
:
  • Drug: Humira Will receive 80 m
Not yet recruiting : Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2017-02-17
: Drug: APD334 Other Name: Etrasimod
Recruiting : Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
: Pyoderma Gangrenosum
: 2016-03-28
: Drug: Secukinumab
Next >>>